NCT03264716View on ClinicalTrials.gov

Transarterial Chemoembolization by Hepasphere Microspheres for the Treatment of Unresectable Colorectal Liver Metastasis

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

August 31, 2017

Primary Completion Date

January 26, 2018

Study Completion Date

September 11, 2018

Conditions
Unresectable Colorectal Liver Metastasis
Interventions
DEVICE

HepaSphere TACE (transarterial chemoembolization)

100 mg doxorubicin will be loaded onto the HepaSphere Microspheres and delivered via microcatheter.

Trial Locations (1)

Unknown

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT03264716 - Transarterial Chemoembolization by Hepasphere Microspheres for the Treatment of Unresectable Colorectal Liver Metastasis | Biotech Hunter | Biotech Hunter